Lakeland Industries (NASDAQ:LAKE) PT Raised to $27.00 at Roth Mkm

Lakeland Industries (NASDAQ:LAKE) had its price target hoisted by research analysts at Roth Mkm from $25.00 to $27.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Roth Mkm’s price objective suggests a potential upside of 21.40% from the company’s current price.

Other equities research analysts also recently issued reports about the company. Maxim Group boosted their target price on Lakeland Industries from $22.00 to $26.00 and gave the stock a “buy” rating in a report on Thursday, June 6th. StockNews.com downgraded shares of Lakeland Industries from a “buy” rating to a “hold” rating in a research report on Wednesday, April 3rd.

Lakeland Industries Price Performance

LAKE opened at $22.24 on Wednesday. Lakeland Industries has a 12-month low of $13.63 and a 12-month high of $24.80. The company has a market cap of $164.13 million, a price-to-earnings ratio of 29.65 and a beta of 0.57. The company has a current ratio of 5.39, a quick ratio of 2.74 and a debt-to-equity ratio of 0.10. The stock has a fifty day simple moving average of $19.79 and a two-hundred day simple moving average of $18.18.

Lakeland Industries (NASDAQ:LAKE) last announced its earnings results on Tuesday, June 4th. The medical instruments supplier reported $0.22 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.16). Lakeland Industries had a net margin of 4.34% and a return on equity of 6.84%. The business had revenue of $36.31 million for the quarter, compared to the consensus estimate of $31.90 million. Research analysts predict that Lakeland Industries will post 1.39 earnings per share for the current fiscal year.

Insider Transactions at Lakeland Industries

In other Lakeland Industries news, CEO James M. Jenkins bought 2,085 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was acquired at an average price of $23.98 per share, with a total value of $49,998.30. Following the transaction, the chief executive officer now owns 75,728 shares in the company, valued at $1,815,957.44. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Lakeland Industries

Large investors have recently added to or reduced their stakes in the stock. Equitable Trust Co. boosted its stake in shares of Lakeland Industries by 10.7% in the 4th quarter. Equitable Trust Co. now owns 27,665 shares of the medical instruments supplier’s stock worth $513,000 after buying an additional 2,680 shares during the last quarter. Quadrature Capital Ltd bought a new position in Lakeland Industries in the fourth quarter valued at about $236,000. North Star Investment Management Corp. lifted its holdings in Lakeland Industries by 0.9% in the first quarter. North Star Investment Management Corp. now owns 168,573 shares of the medical instruments supplier’s stock valued at $3,085,000 after acquiring an additional 1,503 shares during the period. Empowered Funds LLC boosted its position in Lakeland Industries by 6.9% in the first quarter. Empowered Funds LLC now owns 10,873 shares of the medical instruments supplier’s stock worth $199,000 after purchasing an additional 700 shares during the last quarter. Finally, Hillsdale Investment Management Inc. grew its stake in shares of Lakeland Industries by 37.2% during the 1st quarter. Hillsdale Investment Management Inc. now owns 10,700 shares of the medical instruments supplier’s stock valued at $196,000 after purchasing an additional 2,900 shares during the period. Institutional investors own 71.69% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.